Results 61 to 70 of about 694 (96)

Cabozantinib Sensitizes NSCLC Cells to Radiation by Inducing Ferroptosis via STAT3/MCL1/BECN1/SLC7A11 Axis Suppression. [PDF]

Cancers (Basel)
Wang CY, Huang CY, Chen LJ, Chen G, Hong SY.   +4 more
europepmc   +1 more source

Cerebral Metastasis of a Gastrointestinal Stromal Tumor: A Case Report and Literature Review. [PDF]

Cureus
Lopes DD, Pereira R, Couto E, Freitas D, Marques AD.   +4 more
europepmc   +1 more source

Clinical and preclinical insights into a novel MDM2::PDGFRA fusion in recurrent glioblastoma. [PDF]

NPJ Precis Oncol
Beach CZ, Febres-Aldana CA, Marti JLG, Asiry S, Wong T, Boockvar JA, D'Amico RS, Somwar R, Davare MA, Vojnic M.   +9 more
europepmc   +1 more source

Surgical treatment of gastrointestinal stromal tumors. [PDF]

J Med Life
Godja AM, Eftimie AM, Balalau C, Balescu I, Bacalbasa N.   +4 more
europepmc   +1 more source

MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. [PDF]

Clin Cancer Res
Miranda-Román MA, Lee CJ, Fishinevich E, Ran L, Patel AJ, Yan J, Khudoynazarova MN, Warda S, Pachai MR, Chen Y, Chi P.   +10 more
europepmc   +1 more source

Molecular remodeling of the myocardium in mice with melanocortin-4 receptor deletion before cardiac function impairment. [PDF]

PLoS One
Wang X, Qi Y, Zhu Z, Wang C, Zhang Z, Jia H, Xia L, Meng K, Yuan J.   +8 more
europepmc   +1 more source

Targeting MITF as a tyrosine-kinase-inhibitor-independent strategy for treating GIST. [PDF]

Mol Ther Oncol
Yeung SF, Huang Q, Liang K, Wing Tsui SK.   +3 more
europepmc   +1 more source

Pharmacokinetic Drug-Drug Interaction Potential of Oral Anticancer Drugs. [PDF]

Clin Pharmacol Ther
Alhurayri F, Younis IR, Jalal SI, Logan TF, Maniar R, Bray SM, Quinney SK, Desta Z, Skaar TC, Tisdale JE, Shugg T.   +10 more
europepmc   +1 more source

Gastrointestinal Stromal Tumor: History, Molecular Subtypes, and Risk Stratification. [PDF]

J Gastric Cancer
Song IH, Ahn S, Kim HD, Jo JH, Shin J, Ryu MH, Park YS.   +6 more
europepmc   +1 more source

Selection between sunitinib and ripretinib using mutation analysis for gastrointestinal stromal tumor patients progressing on imatinib. [PDF]

Transl Gastroenterol Hepatol
Joensuu H.
europepmc   +1 more source